1. Home
  2. LXU vs RAPP Comparison

LXU vs RAPP Comparison

Compare LXU & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LSB Industries Inc.

LXU

LSB Industries Inc.

HOLD

Current Price

$13.82

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$36.18

Market Cap

1.3B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
LXU
RAPP
Founded
1968
2022
Country
United States
United States
Employees
513
N/A
Industry
Major Chemicals
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.3B
IPO Year
2006
2024

Fundamental Metrics

Financial Performance
Metric
LXU
RAPP
Price
$13.82
$36.18
Analyst Decision
Hold
Strong Buy
Analyst Count
4
6
Target Price
$14.63
$48.50
AVG Volume (30 Days)
1.9M
240.6K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
225.93
24.34
EPS
0.34
N/A
Revenue
$615,208,000.00
N/A
Revenue This Year
$10.78
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$41.94
N/A
Revenue Growth
17.77
N/A
52 Week Low
$4.92
$7.73
52 Week High
$17.22
$42.27

Technical Indicators

Market Signals
Indicator
LXU
RAPP
Relative Strength Index (RSI) 47.51 72.76
Support Level $7.88 $25.48
Resistance Level $15.66 $42.27
Average True Range (ATR) 0.99 1.97
MACD -0.33 0.58
Stochastic Oscillator 17.29 96.56

Price Performance

Historical Comparison
LXU
RAPP

About LXU LSB Industries Inc.

LSB Industries Inc is engaged in the manufacturing and sale of chemical products in the United States. The company manufactures and sells chemical products for the agricultural and industrial sectors. Its products include ammonia, fertilizer grade ammonium nitrate (AN and HDAN), and urea ammonia nitrate (UAN) for agricultural applications; high purity and commercial grade ammonia, sulfuric acids, concentrated, blended, and regular nitric acid, mixed nitrating acids, carbon dioxide, and diesel exhaust fluid for industrial applications; and industrial grade AN (LDAN) and AN solutions for mining applications. Its products are sold through distributors and directly to end customers throughout the United States and other parts of North America.

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: